loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

Related Intermediates: CAS 446292-10-0

Client Email Product
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 Suanfarma (1)

02 Aarti Pharmalabs (4)

03 Valsynthese (1)

04 Synnat Pharma (2)

05 Kimia Biosciences (3)

06 Shandong Boyuan Pharmaceutical (6)

07 Actis Generics Pvt Ltd (4)

08 Aragen Life Sciences (3)

09 Cangzhou Enke Pharma-tech Co., Ltd (3)

10 Cangzhou Senary Chemical Science-tech Co., Ltd (3)

11 Chengda Pharmaceuticals (1)

12 HUNAN OUYA BIOLOGICAL CO.,LTD (2)

13 Hangzhou Longshine Bio-Tech Co.,LTD (5)

14 Indian Drugs And Chemicals (3)

15 Indian Tex Dyes Industries (6)

16 Inventys (1)

17 Luna Chemicals (3)

18 Nantong Chem-land (5)

19 Omshri Labs (3)

20 Prajna Generics (2)

21 Royal Pharma (5)

22 SPC Lifesciences Pvt. Ltd (2)

23 SS Pharma (7)

24 Sandoo Pharmaceuticals and Chemcials Co.,Ltd (1)

25 Srini Pharmaceuticals (6)

26 Synaptic Labs (4)

27 Synthland Limited (1)

28 ZCL CHEMICALS LTD (2)

530-62-1
Rivaroxaban
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.
438056-69-0
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

161596-47-0
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

24065-33-6
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

446292-08-6
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

438056-69-0
Rivaroxaban
Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it ...
Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it has a broad international reach. With over a century of experience in highly hazardous and energetic chemistry, it has the expertise to develop fine chemical projects and has established the capability to produce key chemical intermediates and APIs under GMP and ISO certification. Valsynthese is regarded as one of Europe's most experienced CDMO chemical producers. It offers a variety of projects, ranging from lab procedures to tonne-scale manufacturing. It supplies its customers with high-quality products at competitive prices.
898543-06-1
Rivaroxaban
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, prod...
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. APIs manufactured by Synnat are used by major drug formulators worldwide. Manufacturing activities are carried out as per ICH cGMP guidelines and several conventional and modern techniques are used for the isolation, semi-synthesis and purification of its products. Synnat Pharma has a presence in semi-regulated and non-regulated markets and is now entering regulated markets.
42518-98-9
Rivaroxaban
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, prod...
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. APIs manufactured by Synnat are used by major drug formulators worldwide. Manufacturing activities are carried out as per ICH cGMP guidelines and several conventional and modern techniques are used for the isolation, semi-synthesis and purification of its products. Synnat Pharma has a presence in semi-regulated and non-regulated markets and is now entering regulated markets.
URL Supplier Web Content
446292-07-5
Rivaroxaban
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic se...
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia aims to become a globally recognized company in both APIs and FDFs while upholding clean business practices. Kimia's state-of-the-art facilities at Village Bhondsi, Gurugram enable it to produce a wide range of APIs. Kimia also plans to establish its own facilities for lifestyle segments, adhering to international regulatory standards. Kimia aims to provide the best pharmaceutical products and support to consumers and healthcare professionals.
Kimia Biosciences

Iran Expo

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
446292-08-6
Rivaroxaban
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic se...
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia aims to become a globally recognized company in both APIs and FDFs while upholding clean business practices. Kimia's state-of-the-art facilities at Village Bhondsi, Gurugram enable it to produce a wide range of APIs. Kimia also plans to establish its own facilities for lifestyle segments, adhering to international regulatory standards. Kimia aims to provide the best pharmaceutical products and support to consumers and healthcare professionals.
Kimia Biosciences

Iran Expo

Not Confirmed

envelop Contact Supplier
Post Enquiry
POST ENQUIRY